Genprex (GNPX) Non Operating Investment Income (2023 - 2024)
Genprex (GNPX) posted quarterly Non Operating Investment Income of $545.0 for Q4 2024, up 161.51% year-over-year from $208.4 in Q1 2024, and up 186.65% quarter-over-quarter from -$629.0 in Q3 2024.
Genprex (GNPX) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Genprex's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $545.0 for Q4 2024.
- In Q4 2024, Non Operating Investment Income rose 161.51% year-over-year to $545.0; the TTM figure through Dec 2024 stood at -$569.0 (up 96.95% YoY), while the FY2025 annual figure was -$299.0, up 47.54% from the prior year.
- Non Operating Investment Income for Q4 2024 stood at $545.0, up from -$629.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $2208.0 in Q2 2023, with the low at -$13307.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Genprex | 1.88 Mn | -13.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 545.00 |
| Dec 31, 2024 | 545.00 |
| Sep 30, 2024 | -629.00 |
| Sep 30, 2024 | -629.00 |
| Jun 30, 2024 | -620.00 |
| Jun 30, 2024 | -620.00 |
| Mar 31, 2024 | 135.00 |
| Mar 31, 2024 | 135.00 |
| Dec 31, 2023 | -886.00 |
| Dec 31, 2023 | -886.00 |
| Sep 30, 2023 | -13,307.00 |
| Sep 30, 2023 | -13,307.00 |
| Jun 30, 2023 | 2,208.00 |
| Jun 30, 2023 | 2,208.00 |
| Mar 31, 2023 | -6,691.00 |
| Mar 31, 2023 | -6,691.00 |